Steven E. McNulty

20.6k total citations · 6 hit papers
59 papers, 10.1k citations indexed

About

Steven E. McNulty is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Steven E. McNulty has authored 59 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Steven E. McNulty's work include Heart Failure Treatment and Management (36 papers), Cardiovascular Function and Risk Factors (27 papers) and Cardiac pacing and defibrillation studies (16 papers). Steven E. McNulty is often cited by papers focused on Heart Failure Treatment and Management (36 papers), Cardiovascular Function and Risk Factors (27 papers) and Cardiac pacing and defibrillation studies (16 papers). Steven E. McNulty collaborates with scholars based in United States, Canada and United Kingdom. Steven E. McNulty's co-authors include Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, Jill Anderson, George Johnson, Douglas L. Packer, Nancy E. Clapp‐Channing, James E. Ip and Linda Davidson‐Ray and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Steven E. McNulty

59 papers receiving 9.7k citations

Hit Papers

Amiodarone or an Implantable Cardioverter–Defibrillator f... 2005 2026 2012 2019 2005 2020 2016 2009 2015 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. McNulty United States 32 8.9k 1.4k 1.1k 1.1k 649 59 10.1k
Jalal K. Ghali United States 50 7.7k 0.9× 1.2k 0.9× 1.5k 1.4× 974 0.9× 447 0.7× 161 9.9k
Gianluigi Savarese Sweden 44 7.7k 0.9× 1.5k 1.1× 1.6k 1.5× 1.8k 1.7× 694 1.1× 299 10.6k
Kenneth Dickstein Norway 33 5.7k 0.6× 871 0.6× 875 0.8× 851 0.8× 413 0.6× 105 7.1k
Alain Cohen‐Solal France 61 11.0k 1.2× 1.7k 1.3× 1.9k 1.8× 896 0.8× 1.1k 1.6× 250 13.7k
Michele Senni Italy 44 6.6k 0.7× 1.3k 0.9× 1.1k 1.0× 1.0k 1.0× 527 0.8× 290 8.4k
JoAnn Lindenfeld United States 28 4.6k 0.5× 1.3k 0.9× 792 0.7× 625 0.6× 730 1.1× 79 6.2k
Wilfried Müllens Belgium 50 8.2k 0.9× 1.9k 1.4× 3.2k 3.0× 738 0.7× 1.1k 1.7× 267 11.0k
Kevin Damman Netherlands 56 8.4k 0.9× 1.7k 1.2× 3.4k 3.2× 1.6k 1.5× 975 1.5× 194 11.8k
Andrew P. Ambrosy United States 36 4.9k 0.6× 848 0.6× 1.2k 1.1× 612 0.6× 516 0.8× 200 6.3k
Kenneth Dickstein Norway 47 8.7k 1.0× 1.1k 0.8× 1.3k 1.2× 1.1k 1.0× 619 1.0× 166 11.9k

Countries citing papers authored by Steven E. McNulty

Since Specialization
Citations

This map shows the geographic impact of Steven E. McNulty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. McNulty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. McNulty more than expected).

Fields of papers citing papers by Steven E. McNulty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. McNulty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. McNulty. The network helps show where Steven E. McNulty may publish in the future.

Co-authorship network of co-authors of Steven E. McNulty

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. McNulty. A scholar is included among the top collaborators of Steven E. McNulty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. McNulty. Steven E. McNulty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vader, Justin, Michael M. Givertz, Randall C. Starling, et al.. (2022). Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure. JACC Heart Failure. 10(7). 449–456. 16 indexed citations
2.
Sharma, Abhinav, Stephen J. Greene, Muthiah Vaduganathan, et al.. (2021). Growth Differentiation Factor-15, Treatment with Liraglutide, and Clinical Outcomes Among Patients with Heart Failure. ESC Heart Failure. 8(4). 2608–2616. 11 indexed citations
3.
Mann, Douglas L., Stephen J. Greene, Michael M. Givertz, et al.. (2020). Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 8(10). 789–799. 37 indexed citations
4.
Reddy, Yogesh N.V., Masaru Obokata, Sanjiv J. Shah, et al.. (2020). Quality of Life in Heart Failure with Preserved Ejection Fraction: Importance of Obesity, Functional Capacity, and Physical Inactivity. European Journal of Heart Failure. 22(6). 1009–1018. 148 indexed citations
5.
Reddy, Yogesh N.V., Gregory D. Lewis, Sanjiv J. Shah, et al.. (2019). Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study. Mayo Clinic Proceedings. 94(7). 1199–1209. 96 indexed citations
6.
Reddy, Yogesh N.V., Masaru Obokata, Jeffrey M. Testani, et al.. (2019). Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure. 26(2). 101–107. 33 indexed citations
7.
Greene, Stephen J., G. Michael Felker, Anna Giczewska, et al.. (2019). Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. Canadian Journal of Cardiology. 35(9). 1097–1105. 20 indexed citations
8.
Felker, G. Michael, Margaret M. Redfield, Robert J. Mentz, et al.. (2019). Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies. Journal of Cardiac Failure. 25(8). S75–S75. 5 indexed citations
9.
AbouEzzeddine, Omar F., Yee Weng Wong, Robert J. Mentz, et al.. (2015). Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. Journal of Cardiac Failure. 22(11). 853–858. 7 indexed citations
10.
Redfield, Margaret M., Kevin J. Anstrom, James A. Levine, et al.. (2015). Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine. 373(24). 2314–2324. 370 indexed citations breakdown →
11.
AbouEzzeddine, Omar F., Anuradha Lala, Prateeti Khazanie, et al.. (2015). Evaluation of a provocative dyspnea severity score in acute heart failure. American Heart Journal. 172. 34–41. 10 indexed citations
12.
Borlaug, Barry A., Gregory D. Lewis, Steven E. McNulty, et al.. (2015). Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction. Circulation Heart Failure. 8(3). 533–541. 55 indexed citations
13.
Borlaug, Barry A., Gregory D. Lewis, Steven E. McNulty, et al.. (2014). DIVERGING EFFECTS OF SILDENAFIL ON VENTRICULAR-VASCULAR FUNCTION IN HFPEF. Journal of the American College of Cardiology. 63(12). A759–A759. 1 indexed citations
14.
Mentz, Robert J., Justin Vader, Adam D. DeVore, et al.. (2014). DECONGESTION STRATEGIES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN ACUTE HEART FAILURE. Journal of the American College of Cardiology. 63(12). A747–A747. 3 indexed citations
15.
Bishu, Kalkidan, Anita Deswal, Horng H. Chen, et al.. (2012). Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. American Heart Journal. 164(5). 763–770.e3. 89 indexed citations
16.
Shoaibi, Azadeh, Dale R. Tavris, & Steven E. McNulty. (2009). Gender differences in correlates of troponin assay in diagnosis of myocardial infarction. Translational research. 154(5). 250–256. 5 indexed citations
17.
Rao, Sunil V., E. Magnus Ohman, Christopher B. Granger, et al.. (2003). Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. The American Journal of Cardiology. 91(8). 936–940. 51 indexed citations
18.
O’Connor, Christopher M., Wendy A. Gattis, Faı̈ez Zannad, et al.. (1999). Beta-Blocker Therapy in Advanced Heart Failure: Clinical Characteristics and Long-Term Outcomes. European Journal of Heart Failure. 1(1). 81–88. 14 indexed citations
19.
O’Connor, Christopher M., Steven E. McNulty, Robert J. Carney, et al.. (1996). A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The American Journal of Cardiology. 77(10). 791–797. 16 indexed citations
20.
Hathaway, William R., Steven E. McNulty, Karen S. Pieper, et al.. (1995). 901-84 Prognostic Value of Right Heart Catheterization Hemodynamic Data in Surgically Treated Patients with Coronary Artery Disease. Journal of the American College of Cardiology. 25(2). 25A–25A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026